<?xml version="1.0" encoding="UTF-8" standalone="no"?><information><Cell><NavigationPath><Head00>Toxicity</Head00><Stub><SubHeader0>Gastrointestinal</SubHeader0><StubValue> Diarrhoea</StubValue></Stub><HeaderValue>Patients (n=40) Grade 3–4</HeaderValue></NavigationPath><value>2.5%</value><CellType>Partially Numeric</CellType></Cell><Table><tableName>Toxicity of the vinorelbine–HDFL regimen</tableName><TableType>Subheader</TableType><tableOrder>Table 2</tableOrder><tableFooter>aGrade 1.bGrade 2–3.NA=nonapplicable by cycles.</tableFooter></Table><Document><DocumentTitle>Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer</DocumentTitle><PMC>2361932</PMC></Document></information>